Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Calixto Machado
No abstract text is available yet for this article.
May 14, 2024: Neurology
#2
JOURNAL ARTICLE
Maria Vassilaki, Rioghna R Pittock, Jeremiah A Aakre, Anna M Castillo, Vijay K Ramanan, Walter K Kremers, Clifford R Jack, Prashanthi Vemuri, Val J Lowe, David S Knopman, Ronald C Petersen, Jonathan Graff-Radford
No abstract text is available yet for this article.
May 14, 2024: Neurology
#3
JOURNAL ARTICLE
Ariane Lewis, Matthew P Kirschen, David M Greer
No abstract text is available yet for this article.
May 14, 2024: Neurology
#4
JOURNAL ARTICLE
Christopher A DeCock, James Giordano, G Kevin Donovan, Carlo S Tornatore
No abstract text is available yet for this article.
May 14, 2024: Neurology
#5
EDITORIAL
Elizabeth Silbermann, Rebecca I Spain
No abstract text is available yet for this article.
May 14, 2024: Neurology
#6
JOURNAL ARTICLE
David M Greer, Ariane Lewis, Matthew P Kirschen
No abstract text is available yet for this article.
May 14, 2024: Neurology
#7
JOURNAL ARTICLE
Shahed Toossi, Tao Shen, Douglas Dragomer, Michael Nurok
No abstract text is available yet for this article.
May 14, 2024: Neurology
#8
JOURNAL ARTICLE
James E Siegler, Steven Galetta
No abstract text is available yet for this article.
May 14, 2024: Neurology
#9
JOURNAL ARTICLE
Ryan Feldman, Jillian Theobald, Matthew Stanton, Andrew Stolbach, Laura Tormoehlen
No abstract text is available yet for this article.
May 14, 2024: Neurology
#10
JOURNAL ARTICLE
Nitin K Sethi, Prahlad K Sethi
No abstract text is available yet for this article.
May 14, 2024: Neurology
#11
JOURNAL ARTICLE
David M Greer, Ariane Lewis, Matthew P Kirschen, Alexander Rae-Grant, John J Halperin
No abstract text is available yet for this article.
May 14, 2024: Neurology
#12
JOURNAL ARTICLE
Robert J Fox, Bruce A C Cree, Jérôme de Sèze, Ralf Gold, Hans-Peter Hartung, Douglas Jeffery, Ludwig Kappos, Xavier Montalban, Bianca Weinstock-Guttman, Carol M Singh, Arman Altincatal, Nicholas Belviso, Robin L Avila, Pei-Ran Ho, Ray Su, Robert Engle, Dipen Sangurdekar, Carl de Moor, Elizabeth Fisher, Bernd C Kieseier, Richard A Rudick
BACKGROUND AND OBJECTIVES: Serum neurofilament light chain (sNfL) levels correlate with multiple sclerosis (MS) disease activity, but the dynamics of this correlation are unknown. We evaluated the relationship between sNfL levels and radiologic MS disease activity through monthly assessments during the 24-week natalizumab treatment interruption period in RESTORE (NCT01071083). METHODS: In the RESTORE trial, participants with relapsing forms of MS who had received natalizumab for ≥12 months were randomized to either continue or stop natalizumab and followed with MRI and blood draws every 4 weeks to week 28 and again at week 52 The sNfL was measured, and its dynamics were correlated with the development of gadolinium-enhancing (Gd+) lesions...
May 14, 2024: Neurology
#13
JOURNAL ARTICLE
David M Greer, Ariane Lewis, Panayiotis N Varelas, Matthew P Kirschen
No abstract text is available yet for this article.
May 14, 2024: Neurology
#14
JOURNAL ARTICLE
Paolo Salvioni Chiabotti, Olivier Rouaud, Gilles Allali
No abstract text is available yet for this article.
May 14, 2024: Neurology
#15
JOURNAL ARTICLE
Natalia S Rost
No abstract text is available yet for this article.
May 14, 2024: Neurology
#16
JOURNAL ARTICLE
Nils Skajaa, Kristina Laugesen, Julie C Lauffenburger, Lee H Schwamm, Henrik T Sørensen, Elisabetta Patorno
BACKGROUND AND OBJECTIVES: Understanding trends in the use of medications for secondary stroke prevention is crucial for identifying areas for improvement in stroke care. We examined the use of lipid-lowering, antihypertensive, glucose-lowering, oral anticoagulant, and antiplatelet medications after ischemic stroke hospitalization, from 2005 to 2021. METHODS: Using nationwide registries in Denmark, we identified a cohort of patients discharged from hospital with a first-time or recurrent ischemic stroke (N = 150,744)...
May 14, 2024: Neurology
#17
EDITORIAL
Mika Kivimaki, Archana Singh-Manoux
No abstract text is available yet for this article.
May 14, 2024: Neurology
#18
JOURNAL ARTICLE
James E Siegler, Steven Galetta
No abstract text is available yet for this article.
May 14, 2024: Neurology
#19
JOURNAL ARTICLE
Ariane Lewis, Steven Galetta
No abstract text is available yet for this article.
May 14, 2024: Neurology
#20
JOURNAL ARTICLE
Christopher E J Doppler, Aline Seger, Ezequiel Farrher, Cláudia Régio Brambilla, Lukas Hensel, Christian P Filss, Martin Hellmich, Ana Gogishvili, N Jon Shah, Christoph W Lerche, Bernd Neumaier, Karl-Josef Langen, Gereon R Fink, Michael Sommerauer
BACKGROUND AND OBJECTIVES: Clinical heterogeneity of patients with Parkinson disease (PD) is well recognized. PD with REM sleep behavior disorder (RBD) is a more malignant phenotype with faster motor progression and higher nonmotor symptom burden. However, the neural mechanisms underlying this clinical divergence concerning imbalances in neurotransmitter systems remain elusive. METHODS: Combining magnetic resonance (MR) spectroscopy and [11 C]ABP688 PET on a PET/MR hybrid system, we simultaneously investigated two different mechanisms of glutamate signaling in patients with PD...
May 14, 2024: Neurology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
